Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AHG Akso Health Group	$1.91 +7.3%	$1.49	$0.74 ▼ $2.35	$272.50M	-0.7	69,507 shs	19,332 shs
BGSF BGSF	$6.55 +0.3%	$5.29	$2.91 ▼ $9.06	$72.76M	1.13	43,277 shs	33,251 shs
EGHT 8X8	$1.93 -1.5%	$1.85	$1.51 ▼ $3.52	$259.54M	1.83	1.09 million shs	598,501 shs
OABI OmniAb	$1.95 -0.5%	$1.65	$1.22 ▼ $4.96	$238.16M	0.14	650,338 shs	644,930 shs

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AHG Akso Health Group	0.00%	+11.05%	+36.04%	+67.54%	+81.89%
BGSF BGSF	0.00%	0.00%	+18.23%	+113.36%	-25.31%
EGHT 8X8	0.00%	0.00%	+4.89%	+22.54%	-33.90%
OABI OmniAb	0.00%	-3.94%	+18.18%	+8.94%	-59.12%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AHG Akso Health Group	0.0996 of 5 stars	0.0	3.0	0.0	0.6	0.0	0.0
BGSF BGSF	4.3734 of 5 stars	3.8	3.0	4.0	3.4	0.0	1.3
EGHT 8X8	3.2795 of 5 stars	3.0	3.0	0.0	2.5	2.5	1.9
OABI OmniAb	2.3283 of 5 stars	3.5	1.0	0.0	0.0	3.3	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AHG Akso Health Group	0.00	N/A	N/A	N/A
BGSF BGSF	3.50	Strong Buy	$9.00	37.40% Upside
EGHT 8X8	2.00	Hold	$2.51	30.27% Upside
OABI OmniAb	3.00	Buy	$7.00	258.97% Upside

Current Analyst Ratings Breakdown

Latest BGSF, EGHT, OABI, and AHG Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/12/2025	EGHT 8X8	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (D-) ➝ Sell (D-)
6/27/2025	EGHT 8X8	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (D-) ➝ Sell (D-)
6/23/2025	BGSF BGSF	Taglich Brothers Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Moderate Buy ➝ Strong-Buy
6/11/2025	EGHT 8X8	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (D-) ➝ Sell (D-)
5/24/2025	EGHT 8X8	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (D-) ➝ Sell (D-)
5/20/2025	EGHT 8X8	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$2.70 ➝ $2.70
5/14/2025	EGHT 8X8	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$4.00 ➝ $3.00
5/12/2025	OABI OmniAb	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$6.00 ➝ $6.00
5/10/2025	EGHT 8X8	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (D-) ➝ Sell (D-)
4/24/2025	EGHT 8X8	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (D-) ➝ Sell (D-)
4/24/2025	EGHT 8X8	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$3.30 ➝ $2.70

(Data available from 7/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AHG Akso Health Group	$2.41M	115.49	N/A	N/A	$0.95 per share	2.01
BGSF BGSF	$272.50M	0.27	$0.44 per share	14.87	$7.46 per share	0.88
EGHT 8X8	$715.07M	0.36	$0.65 per share	2.95	$0.93 per share	2.08
OABI OmniAb	$26.39M	9.03	N/A	N/A	$2.37 per share	0.82

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AHG Akso Health Group	-$9.46M	N/A	0.00	∞	N/A	N/A	N/A	N/A	7/29/2025 (Estimated)
BGSF BGSF	-$3.34M	-$0.31	N/A	59.55	N/A	-1.22%	-3.96%	-2.11%	8/6/2025 (Estimated)
EGHT 8X8	-$27.21M	-$0.21	N/A	19.30	N/A	-3.81%	5.73%	0.90%	N/A
OABI OmniAb	-$62.03M	-$0.58	N/A	N/A	N/A	-229.11%	-21.37%	-18.84%	8/6/2025 (Estimated)

Latest BGSF, EGHT, OABI, and AHG Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2025	Q2 2025	BGSF BGSF	-$0.01	N/A	N/A	N/A	$66.50 million	N/A
8/6/2025	Q2 2025	OABI OmniAb	-$0.1517	N/A	N/A	N/A	$5.33 million	N/A
5/8/2025	Q1 2025	OABI OmniAb	-$0.17	-$0.17	N/A	-$0.17	$4.49 million	$4.15 million
5/7/2025	Q1 2025	BGSF BGSF	-$0.18	-$0.07	+$0.11	-$0.07	$62.00 million	$63.23 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AHG Akso Health Group	N/A	N/A	N/A	N/A	N/A
BGSF BGSF	N/A	N/A	N/A	N/A	N/A
EGHT 8X8	N/A	N/A	N/A	N/A	N/A
OABI OmniAb	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AHG Akso Health Group	N/A	N/A	N/A
BGSF BGSF	0.48	1.76	1.76
EGHT 8X8	2.77	1.20	1.20
OABI OmniAb	N/A	4.70	4.70

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AHG Akso Health Group	1.21%
BGSF BGSF	37.19%
EGHT 8X8	93.99%
OABI OmniAb	72.08%

Insider Ownership

Company	Insider Ownership
AHG Akso Health Group	N/A
BGSF BGSF	7.00%
EGHT 8X8	2.01%
OABI OmniAb	8.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AHG Akso Health Group	40	145.72 million	N/A	Not Optionable
BGSF BGSF	400	11.11 million	10.33 million	Optionable
EGHT 8X8	1,942	134.48 million	131.78 million	Optionable
OABI OmniAb	7	122.14 million	111.63 million	Optionable

BGSF, EGHT, OABI, and AHG Headlines

Recent News About These Companies

OmniAb to Report Second Quarter 2025 Financial Results on August 6

July 16, 2025 | businesswire.com

Positive week for OmniAb, Inc. (NASDAQ:OABI) institutional investors who lost 47% over the past year

July 4, 2025 | finance.yahoo.com

Chairman of OmniAb Picks Up 3.0% More Stock

May 19, 2025 | uk.finance.yahoo.com

OmniAb, Inc. (NASDAQ:OABI) Director Steven Love Purchases 25,000 Shares

May 15, 2025 | insidertrades.com

Insider Buying: OmniAb, Inc. (NASDAQ:OABI) Director Buys 65,000 Shares of Stock

May 14, 2025 | insidertrades.com

OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit

May 13, 2025 | businesswire.com

Is OmniAb, Inc. (OABI) the Low Risk High Reward Stock Set to Triple by 2030?

May 10, 2025 | insidermonkey.com

OmniAb, Inc. (NASDAQ:OABI) Q1 2025 Earnings Call Transcript

May 10, 2025 | msn.com

OmniAb, Inc. (OABI) Q1 2025 Earnings Call Transcript

May 10, 2025 | seekingalpha.com

OmniAb Introduces the xPloration® Partner Access Program

May 9, 2025 | tmcnet.com

OmniAb, Inc. (OABI) Reports Q1 Loss, Misses Revenue Estimates

May 8, 2025 | zacks.com

OmniAb Reports First Quarter 2025 Financial Results and Business Highlights

May 8, 2025 | businesswire.com

VERAXA Biotech AG and OmniAb, Inc. Announce Co-Discovery Alliance for Novel Bispecific Antibody Drug Conjugate Program Targeting Solid Tumors

May 5, 2025 | quiverquant.comQ

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

May 5, 2025 | globenewswire.com

Companies Like OmniAb (NASDAQ:OABI) Are In A Position To Invest In Growth

April 25, 2025 | finance.yahoo.com

OmniAb Announces Two New Appointments to its Board of Directors

April 21, 2025 | finance.yahoo.com

OmniAb Appoints New Directors to Board

April 21, 2025 | tipranks.com

Leerink Partners Sticks to Their Buy Rating for OmniAb (OABI)

April 20, 2025 | markets.businessinsider.com

Kurt A. Gustafson Sells 11,963 Shares of OmniAb, Inc. (NASDAQ:OABI) Stock

April 2, 2025 | insidertrades.com

Analyst Forecasts Just Became More Bearish On OmniAb, Inc. (NASDAQ:OABI)

March 29, 2025 | uk.finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

BGSF, EGHT, OABI, and AHG Company Descriptions

Akso Health Group NASDAQ:AHG

$1.91 +0.13 (+7.30%)

Closing price 07/18/2025 03:58 PM Eastern

Extended Trading

$1.90 -0.01 (-0.79%)

As of 07/18/2025 06:40 PM Eastern

Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.

BGSF NYSE:BGSF

$6.55 +0.02 (+0.31%)

Closing price 07/18/2025 03:58 PM Eastern

Extended Trading

$6.55 0.00 (0.00%)

As of 07/18/2025 04:04 PM Eastern

BGSF, Inc., together with its subsidiaries, provides consulting, managed services, and professional workforce solutions in the United States. It operates in two segments, Property Management and Professional. The Property Management segment offers office and maintenance field talent to various apartment communities and commercial buildings. The Professional segment provides skilled IT professionals in SAP, Workday, Peoplesoft, Hyperion, Oracle, One Stream, cyber, project management, management services, and other IT workforce solutions. This segment also offers finance, accounting, legal, human resource, and related support personnel. It serves its products to fortune 500 companies, and medium and small companies, as well as consulting companies. The company was formerly known as BG Staffing, Inc. and changed its name to BGSF, Inc. in February 2021. BGSF, Inc. was incorporated in 2007 and is based in Plano, Texas.

8X8 NASDAQ:EGHT

$1.93 -0.03 (-1.53%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$1.98 +0.05 (+2.54%)

As of 07/18/2025 07:56 PM Eastern

8x8, Inc. engages in the provision of enterprise communication solutions. It offers solutions to the business services, education, financial services, government, healthcare, and manufacturing industries. The company was founded in February 1987 and is headquartered in Campbell, CA.

OmniAb NASDAQ:OABI

$1.95 -0.01 (-0.51%)

Closing price 07/18/2025 04:00 PM Eastern

Extended Trading

$1.95 0.00 (0.00%)

As of 07/18/2025 06:57 PM Eastern

OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic, a bispecific rat, and OmniClic, a bispecific chicken, designed for discovery of bispecific antibody applications; OmniTaur, which provides unique structural characteristics of cow antibodies for complex targets; and OmniDeep, a suite of in silico, an AI and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time